Bin-Nan Wu Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

2/2022	Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension.
6/2021	Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin.
1/2021	Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition.
8/2020	Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor.
1/2020	The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin-Nan Wu Research Topics

Disease

9	Inflammation (Inflammations) 10/2021 - 06/2011
7	Hyperglycemia 01/2022 - 01/2015
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2016
7	Neuralgia (Stump Neuralgia) 11/2021 - 05/2014
6	Hypertension (High Blood Pressure) 02/2022 - 06/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 01/2020
5	Hyperalgesia 11/2021 - 05/2014
5	Pulmonary Hypertension 01/2021 - 11/2010
5	Body Weight (Weight, Body) 09/2018 - 04/2009
5	Right Ventricular Hypertrophy 05/2015 - 05/2010
4	Hyperlipidemias (Hyperlipidemia) 01/2022 - 03/2014
4	Obesity 01/2022 - 04/2009
4	Pain (Aches) 10/2021 - 05/2014
4	Vascular Remodeling 01/2021 - 11/2010
4	Pulmonary Arterial Hypertension 01/2021 - 05/2010
3	Atrial Fibrillation 02/2022 - 01/2016
3	Myocardial Infarction 02/2022 - 01/2011
3	Fibrosis (Cirrhosis) 08/2021 - 03/2010
3	Neuroinflammatory Diseases 02/2020 - 06/2015
3	Left Ventricular Dysfunction 01/2020 - 01/2011
3	Hypoxia (Hypoxemia) 01/2019 - 05/2015
3	Necrosis 06/2011 - 08/2004
2	Vascular Calcification 05/2022 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2022
2	Cardiac Arrhythmias (Arrythmia) 02/2022 - 08/2020
2	Weight Gain 01/2022 - 04/2009
2	Insulin Resistance 10/2021 - 01/2018
2	Stress Urinary Incontinence 09/2021 - 01/2020
2	Overactive Urinary Bladder (Overactive Bladder) 08/2021 - 01/2018
2	Diabetes Mellitus 04/2021 - 03/2018
2	Cardiomegaly (Heart Hypertrophy) 06/2019 - 03/2010
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2014 - 08/2012
2	Hyperplasia 01/2014 - 09/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2014 - 05/2009
2	Hypertrophy 01/2013 - 03/2010
2	Hypotension (Low Blood Pressure) 01/2005 - 09/2004

Drug/Important Bio-Agent (IBA)

21	KMUP 1IBA 05/2021 - 09/2007
12	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2011
9	eugenosedin-AIBA 01/2022 - 01/2005
9	rho-Associated KinasesIBA 01/2017 - 05/2010
8	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 04/2009
7	XanthineIBA 01/2021 - 03/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020 - 06/2007
5	Theophylline (Theon)FDA LinkGeneric 04/2019 - 05/2014
5	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 11/2010
4	Matrix Metalloproteinases (MMPs)IBA 05/2021 - 01/2011
4	LipidsIBA 04/2021 - 04/2009
4	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 04/2019 - 03/2010
4	Endothelin-1 (Endothelin 1)IBA 01/2019 - 01/2014
3	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2022 - 08/2020
3	Sodium-Glucose Transporter 2IBA 02/2022 - 08/2020
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2018
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2005
3	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 03/2018
3	Glyburide (Glibenclamide)FDA LinkGeneric 01/2022 - 08/2020
3	loganinIBA 11/2021 - 02/2020
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2018 - 06/2014
3	Insulin (Novolin)FDA Link 03/2018 - 04/2009
3	chlorobenzeneIBA 12/2016 - 05/2014
3	MonocrotalineIBA 12/2016 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016 - 08/2004
3	Atorvastatin (Lipitor)FDA Link 06/2016 - 06/2011
3	Soluble Guanylyl CyclaseIBA 05/2015 - 06/2010
2	KATP ChannelsIBA 01/2022 - 08/2018
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2018
2	InflammasomesIBA 11/2021 - 01/2020
2	NLR ProteinsIBA 11/2021 - 01/2020
2	IridoidsIBA 11/2021 - 10/2021
2	GlycosidesIBA 11/2021 - 10/2021
2	Superoxide DismutaseIBA 10/2021 - 07/2020
2	Hormones (Hormone)IBA 08/2021 - 01/2018
2	empagliflozinIBA 06/2021 - 08/2020
2	Interleukin-6 (Interleukin 6)IBA 05/2021 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2015
2	AngiotensinsIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2020
2	Vasoconstrictor AgentsIBA 01/2021 - 01/2014
2	diminazene aceturateIBA 01/2021 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 07/2020 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 01/2020
2	CytokinesIBA 02/2020 - 09/2004
2	CalciumIBA 06/2019 - 04/2019
2	CalcineurinIBA 06/2019 - 03/2010
2	VLDL LipoproteinsIBA 06/2019 - 01/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2019 - 03/2010
2	GuanosineIBA 04/2019 - 03/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 06/2015
2	Coenzyme A (CoA)IBA 01/2017 - 06/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 03/2014
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 11/2015
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 06/2016
2	Phosphodiesterase InhibitorsIBA 08/2016 - 11/2015
2	CholesterolIBA 11/2015 - 02/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2015 - 06/2010
2	Sildenafil Citrate (Viagra)FDA Link 05/2015 - 01/2014
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2015 - 01/2005
2	Doxazosin (Cardura)FDA LinkGeneric 01/2014 - 05/2009
2	Protein Kinases (Protein Kinase)IBA 01/2014 - 01/2013

Therapy/Procedure

5	Therapeutics 02/2022 - 09/2007
3	Extracorporeal Shockwave Therapy 09/2021 - 01/2020